Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RISE: Remote vs. In-Person Clinical Trial Methods Evaluation
NCT06822049Phase 3Completed
- Sponsor
- University at Buffalo
- Start
- Mar 2025
- Primary completion
- Aug 2026
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of nicotine patch in nicotine dependence (4 arms), sponsored by University at Buffalo. Primary endpoints: Accrual efficiency/Pre-treatment visits at 1 month, Trial Quality: Retention at 3 months and 2 more. Started Mar 2025; status: completed.
02
Drugs
nicotine patch
03
Conditions
nicotine dependence
Beyond the preview
Go deeper on NCT06822049.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06822049.